Facebook Pixel We are expanding our footprint in high-growth markets, particularly in Europe and Asia | Express Pharma - health - Read this story on Magzter.com
Go Unlimited with Magzter GOLD

Go Unlimited with Magzter GOLD

Get unlimited access to 10,000+ magazines, newspapers and Premium stories for just

$149.99
 
$74.99/Year

Try GOLD - Free

We are expanding our footprint in high-growth markets, particularly in Europe and Asia

Express Pharma

|

April 2025

Cotecna Group is a leading provider of testing, inspection, and certification services, providing regulatory compliance solutions across various industries, including pharma. Sebastien Dannaud, Global CEO, Cotecna shares insights on the company's expansion plans, innovation, and growth strategies for the pharma sector, in an exclusive interview with Lakshmipriya Nair

- Lakshmipriya Nair

We are expanding our footprint in high-growth markets, particularly in Europe and Asia

Can you elaborate on the Cotecna Group's offerings and how they support pharma companies in meeting global regulatory standards, especially in highly regulated markets?

At Cotecna, we understand the critical importance of regulatory compliance in the pharma industry, particularly in highly regulated markets such as Europe and Asia. Our expertise spans across Good Manufacturing Practices. (GMP), Good Laboratory Practices (GLP), Good Distribution Practices (GDP), as well as regulatory requirements set by major bodies such as the EMA and WHO.

To support pharma companies in navigating these complex regulations, we offer comprehensive testing and auditing services conducted onsite. Our specialised facilities, such as SHIVA Lab and Cotecna Life Sciences in India, provide advanced pharma testing and regulatory support, ensuring that products meet stringent safety and quality standards. Similarly, Neotron Food Pharma Lab in Europe offers specialised pharma and nutra testing, with a particular focus on biopharma solutions.

By fostering strong synergies between India and Neotron, we ensure a harmonised global service offering that provides consistency, reliability, and compliance assurance to pharma clients worldwide.

How does Cotecna differentiate itself from competitors in the pharma testing and certification space? Are there specific strategies or expansion plans targeting high-growth regions like the US, Europe, and emerging markets?

Cotecna stands out due to its strong technical and scientific expertise, combined with its agility, responsiveness, and commitment to tailored solutions. We often describe our approach as "smart, agile, and highly responsive." This mindset allows us to deliver faster turnaround times, customised services, and a client-centric approach that ensures we meet the specific needs of our partners.

MORE STORIES FROM Express Pharma

Express Pharma

Express Pharma

Standardisation vs customisation in single-use systems for bioprocessing: What do biopharma companies need?

Priyabrata Pattnaik, CEO, Ami Polymer highlights the balance between standardisation and customisation in single - use systems in biopharma manufacturing

time to read

5 mins

May 2026

Express Pharma

Express Pharma

Ensuring Pharma compliance with testo data measurement technology

Due to the crucial necessity and its direct impact on human health and welfare, Pharma is probably the most important and critical sector among others.

time to read

3 mins

May 2026

Express Pharma

Express Pharma

China+1 moment for pharma: How India can convert opportunity into long-term contracts

Manish Jain, Director, Naprod Life Sciences explains how India must move beyond cost advantage to lead with reliability, quality, and transparency to reshape global pharma supply chains and position itself as a trusted, long-term partner

time to read

3 mins

May 2026

Express Pharma

Express Pharma

Beyond scale: Rethinking new frontiers in building excellence

At the Injectable Innovations Conclave 2026, hosted by Express Pharma, industry leaders examined the trends, technologies and strategies shaping the next phase of injectable growth, reports

time to read

10 mins

May 2026

Express Pharma

Express Pharma

Waters receives CE mark for BD BACTEC FXI Culture System under EU IVDR

Next-generation blood culture system records ~3-hour faster detection time and introduces automated blood volume measurement

time to read

2 mins

May 2026

Express Pharma

Express Pharma

JNPC: Carrying forward a 20-year old legacy

Billed as India's first bulk drug, chemicals and allied manufacturing parks and one of the most successful public-private partnerships (PPP) in the pharma sector, the Jawaharlal Nehru Pharma City (JNPC), also known as Visakha Pharma City, was set up in February 2005 as a PPP initiative by the Govt of Andhra Pradesh (GoAP) through its nodal agency Andhra Pradesh Industrial Infrastructure Corporation (APIIC) with the Ramky Group on a Build-Own-Operate (BOO) basis for 20 years.

time to read

3 mins

May 2026

Express Pharma

Express Pharma

Romaco's sustainable blister packaging line at interpack

At this year's interpack, the Romaco Group will present its sustainable Unity 600 high-speed blister packaging line, featuring – for the first time – the PF 75 stretch bander.

time to read

6 mins

May 2026

Express Pharma

Express Pharma

Even drug-resistant cancer targets can be tackled with the right design strategy

Dr Bajarang Kumbhar, Assistant Professor, Sunandan Divatia School of Science, NMIMS Mumbai, explains how Al-driven computational biology is reshaping CAR-T therapy and highlights how these approaches help cut drug discovery timelines and improve targeted, personalised cancer treatment, in an interaction with Kalyani Sharma

time to read

7 mins

May 2026

Express Pharma

Express Pharma

Navigating legal and regulatory landscape of GLP-1 drugs in India

GLP-1 drugs are drawing sharp regulatory and legal scrutiny, especially with generics entering post-patent expiry. They emphasise that navigating IP, compliance, and marketing rules is now critical for stakeholders

time to read

5 mins

May 2026

Express Pharma

Express Pharma

From back office to brain trust: How life sciences GCCs are redefining leadership hiring in India

Sai Gandhi, Partner, Positive Moves points out that life sciences GCCs in India are moving from support roles to driving core innovation and global strategy. In turn, leadership hiring is shifting toward cross-functional, globally savvy leaders who can deliver enterprise-wide impact

time to read

4 mins

May 2026

Listen

Translate

Share

-
+

Change font size